Shares of DaVita HealthCare Partners Inc. (NYSE:DVA) saw unusually-high trading volume on Friday . Approximately 3,519,496 shares traded hands during mid-day trading, an increase of 258% from the previous session’s volume of 981,810 shares.The stock last traded at $77.91 and had previously closed at $77.58.

DVA has been the subject of several recent research reports. Jefferies Group restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Monday, April 4th. Susquehanna lifted their price objective on DaVita HealthCare Partners from $70.00 to $78.00 and gave the company a “neutral” rating in a report on Wednesday, April 6th. TheStreet upgraded DaVita HealthCare Partners from a “hold” rating to a “buy” rating in a report on Wednesday, May 4th. Robert W. Baird restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Sunday, May 8th. Finally, Wells Fargo & Co. restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Saturday, June 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $78.88.

The stock’s 50-day moving average is $76.70 and its 200-day moving average is $72.31. The company has a market cap of $16.09 billion and a PE ratio of 34.95.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings results on Wednesday, May 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.06. During the same quarter in the prior year, the company posted $0.86 earnings per share. The business had revenue of $3.58 billion for the quarter, compared to analysts’ expectations of $3.51 billion. The business’s revenue for the quarter was up 8.9% compared to the same quarter last year. Analysts forecast that DaVita HealthCare Partners Inc. will post $3.95 EPS for the current year.

In related news, CEO Dennis Kogod sold 40,048 shares of the firm’s stock in a transaction dated Tuesday, May 10th. The stock was sold at an average price of $76.25, for a total transaction of $3,053,660.00. Following the completion of the transaction, the chief executive officer now directly owns 92,716 shares in the company, valued at approximately $7,069,595. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeanine Marie Jiganti sold 1,291 shares of the firm’s stock in a transaction dated Monday, July 11th. The shares were sold at an average price of $78.51, for a total value of $101,356.41. Following the transaction, the insider now owns 5,716 shares of the company’s stock, valued at $448,763.16. The disclosure for this sale can be found here.

A number of institutional investors have recently made changes to their positions in DVA. Whittier Trust Co. boosted its position in shares of DaVita HealthCare Partners by 3.2% in the fourth quarter. Whittier Trust Co. now owns 43,095 shares of the company’s stock worth $3,004,000 after buying an additional 1,338 shares during the period. Mitsubishi UFJ Kokusai Asset Management CO. LTD. boosted its position in shares of DaVita HealthCare Partners by 103.8% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 43,808 shares of the company’s stock worth $3,054,000 after buying an additional 22,310 shares during the period. Aberdeen Asset Management PLC UK boosted its position in shares of DaVita HealthCare Partners by 22.1% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 47,663 shares of the company’s stock worth $3,574,000 after buying an additional 8,611 shares during the period. Principal Financial Group Inc. boosted its position in shares of DaVita HealthCare Partners by 14.5% in the fourth quarter. Principal Financial Group Inc. now owns 2,365,751 shares of the company’s stock worth $164,916,000 after buying an additional 299,194 shares during the period. Finally, Mark Sheptoff Financial Planning LLC boosted its position in shares of DaVita HealthCare Partners by 0.3% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 37,937 shares of the company’s stock worth $2,645,000 after buying an additional 100 shares during the period.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.